An aggressive lymphatic malformation (Gorham's disease) leading to death of a child

Martin Situma1, Angus Alexander, Nicola Weiselthaler

  • 1Department of Paediatric Surgery, The Red Cross War Memorial Children's Hospital, Claremont 7700, Cape Town, South Africa.

Insights

Gorham's disease, a rare bone disorder, can aggressively progress even from a benign-appearing mass. This case highlights the fatal outcome and management difficulties in pediatric patients with this condition.

Area of Science:

  • Oncology
  • Pathology
  • Pediatric Medicine

Background:

  • Gorham's disease (vanishing bone disease) is a rare, benign proliferative disorder of bone of unknown etiology.
  • It is characterized by the progressive replacement of bone with vascular, fibrous, or fatty tissue.
  • Aggressive forms, though rare, pose significant management challenges, particularly in pediatric populations.

Observation:

  • A 10-year-old boy presented with a buttock mass initially suspected to be benign.
  • The mass demonstrated rapid, invasive growth over a short period.
  • Imaging and biopsy confirmed aggressive Gorham's disease with extensive local invasion.

Findings:

  • The case illustrates the potential for rapid progression and widespread infiltration in Gorham's disease.
  • Despite its benign histological nature, the disease exhibited aggressive behavior, leading to a fatal outcome.
  • Management strategies were challenging due to the invasive nature and lack of targeted therapies.

Implications:

  • This case underscores the need for vigilant monitoring and early intervention in pediatric patients diagnosed with Gorham's disease.
  • It highlights the critical importance of considering aggressive differentials even in seemingly benign presentations of bone lesions.
  • Further research into the pathogenesis and effective treatment modalities for aggressive Gorham's disease is warranted.

Related Concept Videos

Goiter01:27

Goiter

Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Esophageal Achalasia01:27

Esophageal Achalasia

Esophageal achalasia is a chronic neurogenic disorder characterized by impaired relaxation of the lower esophageal sphincter (LES) and absent or ineffective peristalsis in the distal esophagus. This leads to a functional obstruction without a physical blockage, despite significant disruption of esophageal motility.EtiologyAchalasia is caused by degeneration of the myenteric (Auerbach's) plexus, specifically the loss of inhibitory ganglion cells that produce vasoactive intestinal peptide (VIP)...